"World's Most Complete Market Research Reports Repository"

Global Tuberculosis Drug Market Insights, Forecast to 2025

This report studies the global market size of Tuberculosis Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Tuberculosis Drug in these regions.
This research report categorizes the global Tuberculosis Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Tuberculosis (TB) is an infectious disease, which is caused by Mycobacterium tuberculosis. These bacteria generally infect human lungs. However, it can infect other body parts/organs as well. Three major types of tuberculosis are found: latent, active, and drug-resistant tuberculosis. Symptoms are not identifiable in case of latent tuberculosis, due to presence of an inactive form of bacteria. In active tuberculosis, symptoms are clearly visible and they can spread from one person to another. Coughing for more than two weeks, chest pain, coughing up blood, chills, fatigue, unintentional weight loss, fever, and loss of appetite are some of the common symptoms of active tuberculosis. HIV/AIDS, severe kidney disease, cancer, diabetes, and malnutrition are some of the key risk factors generally found to be associated with tuberculosis.
Growing prevalence of multi-drug resistant tuberculosis is driving the tuberculosis drugs market. Drug shortages is a major restraint for the tuberculosis drugs market, especially in low- to medium-income countries of the world. Tuberculosis associated with diseases such as HIV/AIDS and conditions such as obesity is extremely difficult to manage. The tuberculosis drugs market can be segmented based on drug class, disease type, end-user, and region. In terms of drug class, the market can be categorized into first-line therapy, second-line therapy, and combination therapy. Isoniazid, Pyrazinamide, Rifampin, and Ethambutol majorly constitute the first-line therapy for TB; while Streptomycin, Capreomycin, Ethionamide, Levofloxacin, and Gatifloxacin are generally considered as a part of the second-line therapy. Second-line therapy is expected to be a rapidly growing segment of the tuberculosis drugs market.
In 2017, the global Tuberculosis Drug market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Tuberculosis Drug market based on company, product type, application and key regions.

The various contributors involved in the value chain of Tuberculosis Drug include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Tuberculosis Drug include
Lupin
Otsuka Novel Products
Pfizer
Sanofi

Market Size Split by Type
First-line Anti-TB Drugs
Second-line Anti-TB Drugs
Market Size Split by Application
Active TB
Latent TB

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Tuberculosis Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Tuberculosis Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Tuberculosis Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Tuberculosis Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Tuberculosis Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Tuberculosis Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Tuberculosis Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Tuberculosis Drug Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Tuberculosis Drug Market Size Growth Rate by Type
1.4.2 First-line Anti-TB Drugs
1.4.3 Second-line Anti-TB Drugs
1.5 Market by Application
1.5.1 Global Tuberculosis Drug Market Size Growth Rate by Application
1.5.2 Active TB
1.5.3 Latent TB
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Tuberculosis Drug Market Size
2.1.1 Global Tuberculosis Drug Revenue 2016-2025
2.1.2 Global Tuberculosis Drug Sales 2016-2025
2.2 Tuberculosis Drug Growth Rate by Regions
2.2.1 Global Tuberculosis Drug Sales by Regions
2.2.2 Global Tuberculosis Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Tuberculosis Drug Sales by Manufacturers
3.1.1 Tuberculosis Drug Sales by Manufacturers
3.1.2 Tuberculosis Drug Sales Market Share by Manufacturers
3.1.3 Global Tuberculosis Drug Market Concentration Ratio (CR5 and HHI)
3.2 Tuberculosis Drug Revenue by Manufacturers
3.2.1 Tuberculosis Drug Revenue by Manufacturers (2016-2018)
3.2.2 Tuberculosis Drug Revenue Share by Manufacturers (2016-2018)
3.3 Tuberculosis Drug Price by Manufacturers
3.4 Tuberculosis Drug Manufacturing Base Distribution, Product Types
3.4.1 Tuberculosis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tuberculosis Drug Product Category
3.4.3 Date of International Manufacturers Enter into Tuberculosis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Tuberculosis Drug Sales by Type
4.2 Global Tuberculosis Drug Revenue by Type
4.3 Tuberculosis Drug Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Tuberculosis Drug Breakdown Data by Application

6 North America
6.1 North America Tuberculosis Drug by Countries
6.1.1 North America Tuberculosis Drug Sales by Countries
6.1.2 North America Tuberculosis Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Tuberculosis Drug by Type
6.3 North America Tuberculosis Drug by Application
6.4 North America Tuberculosis Drug by Company

7 Europe
7.1 Europe Tuberculosis Drug by Countries
7.1.1 Europe Tuberculosis Drug Sales by Countries
7.1.2 Europe Tuberculosis Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tuberculosis Drug by Type
7.3 Europe Tuberculosis Drug by Application
7.4 Europe Tuberculosis Drug by Company

8 Asia Pacific
8.1 Asia Pacific Tuberculosis Drug by Countries
8.1.1 Asia Pacific Tuberculosis Drug Sales by Countries
8.1.2 Asia Pacific Tuberculosis Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Tuberculosis Drug by Type
8.3 Asia Pacific Tuberculosis Drug by Application
8.4 Asia Pacific Tuberculosis Drug by Company

9 Central & South America
9.1 Central & South America Tuberculosis Drug by Countries
9.1.1 Central & South America Tuberculosis Drug Sales by Countries
9.1.2 Central & South America Tuberculosis Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Tuberculosis Drug by Type
9.3 Central & South America Tuberculosis Drug by Application
9.4 Central & South America Tuberculosis Drug by Company

10 Middle East and Africa
10.1 Middle East and Africa Tuberculosis Drug by Countries
10.1.1 Middle East and Africa Tuberculosis Drug Sales by Countries
10.1.2 Middle East and Africa Tuberculosis Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Tuberculosis Drug by Type
10.3 Middle East and Africa Tuberculosis Drug by Application
10.4 Middle East and Africa Tuberculosis Drug by Company

11 Company Profiles
11.1 Lupin
11.1.1 Lupin Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Tuberculosis Drug
11.1.4 Tuberculosis Drug Product Description
11.1.5 Recent Development
11.2 Otsuka Novel Products
11.2.1 Otsuka Novel Products Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Tuberculosis Drug
11.2.4 Tuberculosis Drug Product Description
11.2.5 Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Tuberculosis Drug
11.3.4 Tuberculosis Drug Product Description
11.3.5 Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Tuberculosis Drug
11.4.4 Tuberculosis Drug Product Description
11.4.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Tuberculosis Drug Raw Material
13.1.2 Tuberculosis Drug Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Picture of Tuberculosis Drug
Figure Global Tuberculosis Drug Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Tuberculosis Drug Production Market Share by Types (Product Category) in 2017
Figure First-line Anti-TB Drugs Product Picture
Table Major Manufacturers of First-line Anti-TB Drugs
Figure Second-line Anti-TB Drugs Product Picture
Table Major Manufacturers of Second-line Anti-TB Drugs
Table Global Tuberculosis Drug Market Size Growth Rate by Application 2018-2025 (K MT)
Figure Active TB
Figure Latent TB
Figure Tuberculosis Drug Report Years Considered
Figure Global Tuberculosis Drug Market Size 2016-2025 (Million US$)
Figure Global Tuberculosis Drug Sales 2016-2025 (K MT)
Table Global Tuberculosis Drug Market Size by Regions 2016-2025 (K MT) & (Million US$)
Table Global Tuberculosis Drug Sales by Regions 2016-2025 (K MT)
Table Global Tuberculosis Drug Sales Market Share by Regions 2016-2025
Figure Global Tuberculosis Drug Sales Market Share by Regions 2016-2025
Figure 2017 Global Tuberculosis Drug Sales Market Share by Regions
Table Global Tuberculosis Drug Revenue by Regions 2016-2025 (Million US$)
Table Global Tuberculosis Drug Revenue Market Share by Regions 2016-2025
Figure Global Tuberculosis Drug Revenue Market Share by Regions 2016-2025
Figure 2017 Global Tuberculosis Drug Revenue Market Share by Regions
Table Global Tuberculosis Drug Sales by Manufacturers (2016-2018) (K MT)
Table Global Tuberculosis Drug Sales Share by Manufacturers (2016-2018)
Figure Global Tuberculosis Drug Sales Share by Manufacturers in 2017
Table Tuberculosis Drug Revenue by Manufacturers (2016-2018) (Million US$)
Table Tuberculosis Drug Revenue Share by Manufacturers (2016-2018)
Figure Tuberculosis Drug Value Share by Manufacturers in 2017
Table Global Tuberculosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Tuberculosis Drug Price (2016-2018) (USD/MT)
Table Tuberculosis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Tuberculosis Drug Product Category
Table Date of International Manufacturers Enter into Tuberculosis Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Tuberculosis Drug Sales by Type (2016-2025) (K MT)
Table Global Tuberculosis Drug Sales Share by Type (2016-2025)
Figure Global Tuberculosis Drug Sales Market Share by Type (2016-2025)
Figure Global Tuberculosis Drug Sales Market Share by Type in 2017
Table Global Tuberculosis Drug Revenue by Type (2016-2025) (Million US$)
Table Global Tuberculosis Drug Revenue Share by Type (2016-2025)
Figure Global Tuberculosis Drug Revenue Market Share by Type (2016-2025)
Figure Global Tuberculosis Drug Revenue Market Share by Type in 2017
Table Tuberculosis Drug Price by Type 2013-2018 (USD/MT)
Table Global Tuberculosis Drug Sales by Application (2016-2025) (K MT)
Table Global Tuberculosis Drug Sales Share by Application (2016-2025)
Figure Global Sales Tuberculosis Drug Market Share by Application (2016-2025)
Figure Global Sales Tuberculosis Drug Market Share by Application (2016-2025)
Figure North America Tuberculosis Drug Sales Growth Rate 2016-2025 (K MT)
Figure North America Tuberculosis Drug Revenue Growth Rate 2016-2025 (Million US$)
Table North America Tuberculosis Drug Sales by Countries (2016-2025) (K MT)
Table North America Tuberculosis Drug Sales Market Share by Countries (2016-2025)
Figure 2017 North America Tuberculosis Drug Sales Market Share by Countries
Table North America Tuberculosis Drug Revenue by Countries (2016-2025) (Million US$)
Table North America Tuberculosis Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Tuberculosis Drug Revenue Market Share by Countries
Figure United States Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure United States Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Canada Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Mexico Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Table North America Tuberculosis Drug Sales by Type (2016-2025) (K MT)
Table North America Tuberculosis Drug Sales Market Share by Type (2016-2025)
Figure 2017 North America Tuberculosis Drug Market Share by Type
Table North America Tuberculosis Drug Sales by Application (2016-2025) (K MT)
Table North America Tuberculosis Drug Sales Market Share by Application (2016-2025)
Figure 2017 North America Tuberculosis Drug Market Share by Application
Table North America Tuberculosis Drug Sales by Company (2016-2018) (K MT)
Table North America Tuberculosis Drug Sales Market Share by Company (2016-2018)
Figure North America Tuberculosis Drug Sales Market Share by Company in 2017
Figure Europe Tuberculosis Drug Sales Growth Rate 2016-2025 (K MT)
Figure Europe Tuberculosis Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Tuberculosis Drug Sales by Countries (2016-2025) (K MT)
Table Europe Tuberculosis Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Tuberculosis Drug Sales Market Share by Countries
Table Europe Tuberculosis Drug Revenue by Countries (2016-2025) (Million US$)
Table Europe Tuberculosis Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Tuberculosis Drug Revenue Market Share by Countries
Figure Germany Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Germany Tuberculosis Drug Revenue Growth Rate (2016-2025) (K MT)
Figure France Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure France Tuberculosis Drug Revenue Growth Rate (2016-2025) (K MT)
Figure UK Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure UK Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Italy Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Russia Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Tuberculosis Drug Sales by Type (2016-2025) (K MT)
Table Europe Tuberculosis Drug Sales Market Share by Type (2016-2025)
Figure 2017 Europe Tuberculosis Drug Market Share by Type
Table Europe Tuberculosis Drug Sales by Application (2016-2025) (K MT)
Table Europe Tuberculosis Drug Sales Market Share by Application (2016-2025)
Figure 2017 Europe Tuberculosis Drug Market Share by Application
Table Europe Tuberculosis Drug Sales by Company (2016-2018) (K MT)
Table Europe Tuberculosis Drug Sales Market Share by Company (2016-2018)
Figure Europe Tuberculosis Drug Sales Market Share by Company in 2017
Figure Asia Pacific Tuberculosis Drug Sales Growth Rate 2016-2025 (K MT)
Figure Asia Pacific Tuberculosis Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Tuberculosis Drug Sales by Countries (2016-2025) (K MT)
Table Asia Pacific Tuberculosis Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Tuberculosis Drug Sales Market Share by Countries
Table Asia Pacific Tuberculosis Drug Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Tuberculosis Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Tuberculosis Drug Revenue Market Share by Countries
Figure China Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure China Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Japan Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Korea Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure India Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure India Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Australia Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Indonesia Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Malaysia Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Philippines Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Thailand Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Vietnam Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Singapore Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Tuberculosis Drug Sales by Type (2016-2025) (K MT)
Table Asia Pacific Tuberculosis Drug Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Tuberculosis Drug Market Share by Type
Table Asia Pacific Tuberculosis Drug Sales by Application (2016-2025) (K MT)
Table Asia Pacific Tuberculosis Drug Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Tuberculosis Drug Market Share by Application
Table Asia Pacific Tuberculosis Drug Sales by Company (2016-2018) (K MT)
Table Asia Pacific Tuberculosis Drug Sales Market Share by Company (2016-2018)
Figure Asia Pacific Tuberculosis Drug Sales Market Share by Company in 2017
Figure Central & South America Tuberculosis Drug Sales Growth Rate 2016-2025 (K MT)
Figure Central & South America Tuberculosis Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Tuberculosis Drug Sales by Countries (2016-2025) (K MT)
Table Central & South America Tuberculosis Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Tuberculosis Drug Sales Market Share by Countries
Table Central & South America Tuberculosis Drug Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Tuberculosis Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Tuberculosis Drug Revenue Market Share by Countries
Figure Brazil Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Brazil Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Argentina Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Tuberculosis Drug Sales by Type (2016-2025) (K MT)
Table Central & South America Tuberculosis Drug Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Tuberculosis Drug Market Share by Type
Table Central & South America Tuberculosis Drug Sales by Application (2016-2025) (K MT)
Table Central & South America Tuberculosis Drug Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Tuberculosis Drug Market Share by Application
Table Central & South America Tuberculosis Drug Sales by Company (2016-2018) (K MT)
Table Central & South America Tuberculosis Drug Sales Market Share by Company (2016-2018)
Figure Central & South America Tuberculosis Drug Sales Market Share by Company in 2017
Figure Middle East and Africa Tuberculosis Drug Sales Growth Rate 2016-2025 (K MT)
Figure Middle East and Africa Tuberculosis Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Tuberculosis Drug Sales by Countries (2016-2025) (K MT)
Table Middle East and Africa Tuberculosis Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Tuberculosis Drug Sales Market Share by Countries
Table Middle East and Africa Tuberculosis Drug Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Tuberculosis Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Tuberculosis Drug Revenue Market Share by Countries
Figure GCC Countries Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure GCC Countries Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Turkey Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure Egypt Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Tuberculosis Drug Sales Growth Rate (2016-2025) (K MT)
Figure South Africa Tuberculosis Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Tuberculosis Drug Sales by Type (2016-2025) (K MT)
Table Middle East and Africa Tuberculosis Drug Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Tuberculosis Drug Market Share by Type
Table Middle East and Africa Tuberculosis Drug Sales by Application (2016-2025) (K MT)
Table Middle East and Africa Tuberculosis Drug Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Tuberculosis Drug Market Share by Application
Table Middle East and Africa Tuberculosis Drug Sales by Company (2016-2018) (K MT)
Table Middle East and Africa Tuberculosis Drug Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Tuberculosis Drug Sales Market Share by Company in 2017
Table Lupin Company Details
Table Lupin Tuberculosis Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Lupin Recent Development
Table Otsuka Novel Products Company Details
Table Otsuka Novel Products Tuberculosis Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Otsuka Novel Products Recent Development
Table Pfizer Company Details
Table Pfizer Tuberculosis Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Tuberculosis Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Tuberculosis Drug Value Chain
Table Typical Suppliers of Key Tuberculosis Drug Raw Material
Table Tuberculosis Drug Customers List
Table Tuberculosis Drug Sales Channels
Table Tuberculosis Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type